During the past decade, Kyoritsu Narashinodai Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kyoritsu Narashinodai Hospital" are "Leiomyoma" (1 trials) and "Uterine Fibroids and Heavy Menstrual Bleeding" (1 trials). Many other conditions were trialed in "Kyoritsu Narashinodai Hospital" in a lesser frequency.

Most popular intervention types in "Kyoritsu Narashinodai Hospital" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vilaprisan (BAY1002670)" (2 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyoritsu Narashinodai Hospital" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kyoritsu Narashinodai Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kyoritsu Narashinodai Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kyoritsu Narashinodai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".